Date of management change: January 17, 2009
Newton, MA-based Pro Pharmaceuticals, Inc. appointed David Platt as Chief Technology Officer.
DAVANAT, the Company's lead product candidate, is a targeted therapeutic compound composed of a complex carbohydrate polymer. DAVANAT's mechanism of action is targeting lectins on the tumor cell surface.
David Platt was previously the CEO and President of Pro-Pharmaceuticals.
Press Release
Short ProfileName: David Platt
Title: Chief Technology Officer
Company: Pro Pharmaceuticals, Inc.
Industry: Business Services Other
Current Contact InfoEmail: *****@pro-pharmaceuticals.com
Phone:.***.***.*03*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Johnson Rani, Falk Kevin, Vandenakker Alec, Hawthorne Suzanne, Bryant Doug, Panopoulos Jules, Dubovik Erik, Crow Scott, Mushumanski Greg, Patel Preeti, Travis Jeremy
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
